A Phase 1/2 Safety and Efficacy Study of INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 1/2 Safety and Efficacy Study of INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.